Spravato® Therapy for Depression Offered at Wheeler’s Family Health & Wellness Centers in Hartford and Waterbury
The winter season, especially, underscores the persistent, sometimes serious challenges for individuals with depression. A new, highly effective treatment for depression, Spravato® therapy (esketamine), is available to adult patients through Wheeler’s Hartford and Waterbury Family Health & Wellness Centers. Caring, skilled teams work closely with individuals in a specially designed suite for patients receiving this treatment.
Talk with your Wheeler provider or call our Navigation Center at 860.793.3500.
Spravato® (esketamine) is the first prescription nasal spray that is taken with an oral antidepressant to treat adults with treatment-resistant depression (TRD). This form of depression applies to patients struggling with major depressive disorder who have not responded adequately to two or more antidepressants. This treatment also is suitable for individuals with major depressive disorder who have suicidal thoughts. Above: Wheeler's Hartford Spravato® team
“We are pleased to offer this safe, effective treatment to our patients who might not have otherwise had access,” said Sabrina Trocchi, PhD, MPA, president and chief executive officer, Wheeler. “Depression is a serious issue, but there is hope for individuals who are struggling.”
Individuals interested in an assessment for Spravato® therapy may contact their Wheeler health care provider or community provider to request a referral. Wheeler’s Waterbury community health center is located at 855 Lakewood Road, and its Hartford community health center is located at 43 Woodland Street.
Pictured at left: Wheeler's Waterbury Spravato® team
Information is also available through Wheeler’s Navigation Center at 860.793.3500.
